Company Filing History:
Years Active: 2018
Title: Innovations in Fibrosis Treatment by Ann Harris
Introduction
Ann Harris is an accomplished inventor based in Chicago, IL (US). She has made significant contributions to the field of medical research, particularly in the treatment of fibrotic diseases. Her innovative work focuses on the use of microRNAs to target specific pathways involved in fibrosis.
Latest Patents
Ann Harris holds a patent for her groundbreaking invention titled "MicroRNA treatment of fibrosis." This patent provides insights into microRNAs that target transforming growth factor beta (TGF-β) receptors, effectively attenuating pathways of fibrosis. Notably, microRNA-1343 has been identified to reduce the expression of TGFBR1 and TGFBR2, decrease TGF-β signaling, and repress pathways of fibrosis, offering a potential treatment for fibrotic diseases.
Career Highlights
Ann Harris is affiliated with Ann & Robert H. Lurie Children's Hospital, where she continues her research and development efforts. Her work has garnered attention for its potential to revolutionize the treatment of conditions related to fibrosis.
Collaborations
Ann collaborates with Lindsay R. Stolzenburg, who is also a key figure in her research endeavors. Their partnership enhances the scope and impact of their work in the medical field.
Conclusion
Ann Harris's innovative approach to treating fibrosis through microRNA technology represents a significant advancement in medical research. Her contributions are paving the way for new therapeutic options for patients suffering from fibrotic diseases.